Clinical trial

Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

NCT02830165

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-06-15

PhaseNA

Study timeline

Study start (actual)2016-06-15Date precision: day

Registry last updated2024-05-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7unresolved

Stage II Prostate Adenocarcinoma AJCC v7unresolved

Stage III Prostate Adenocarcinoma AJCC v7unresolved

Interventions

Laboratory Biomarker AnalysisOTHER

Quality-of-Life AssessmentOTHER

Stereotactic Body Radiation TherapyRADIATION

Sponsors & collaborators

Jonsson Comprehensive Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

Los AngelesCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02830165 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.